IMMUNOGENIC RNA IN THE IMMUNOTHERAPY OF CANCER: THE TRANSFER OF ANTITUMOR CYTOTOXIC ACTIVITY AND TUBERCULIN SENSITIVITY TO HUMAN LYMPHOCYTES USING XENOGENEIC RIBONUCLEIC ACID*
- 1 May 1973
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 207 (1) , 454-467
- https://doi.org/10.1111/j.1749-6632.1973.tb47508.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Improved Flow Rates with Porous Sephadex GelsScience, 1972
- A Sensitive and Reproducible Assay for the Quantitation of the MIF Correlate of Delayed Hypersensitivity in ManImmunological Communications, 1972
- Conversion of Non-Immune Rabbit Spleen Cells by Ribonucleic Acid of Lymphoid Cells from an Immunized Rabbit to Produce IgM and IgG Antibody of Foreign Heavy-Chain AllotypeThe Journal of Immunology, 1971
- Antibody Formation Against Salmonella Flagella by an Immune Ribonucleic Acid FractionThe Journal of Immunology, 1971
- RNA-mediated transfer of tumor immunity —A new model for the immunotherapy of cancerCancer, 1971
- Interspecies “Transfer” of Delayed Hypersensitivity In Vitro with Rna ExtractsThe Journal of Immunology, 1970
- In Vitro Induction of Sulfanilic Acid-Specific Antibodies by RNA Extracted from Rat SpleenThe Journal of Immunology, 1970
- PROTECTION OF C3H MICE AGAINST BP8 TUMOUR BY RNA EXTRACTED FROM LYMPH‐NODES AND SPLEENS OF SPECIFICALLY SENSITIZED MICEActa Pathologica Microbiologica Scandinavica, 1969
- Transfer Agent of ImmunityJapanese Journal of Microbiology, 1969
- Effect of Nucleic Acids from Immune Lymphocytes on Rat SarcomataNature, 1967